Olfactory impairment in older adults: Five-year incidence and risk factors

Laryngoscope

Volumn 121, Issue 4, 2011, Pages 873-878

  Schubert, Carla R ^a,b   Cruickshanks, Karen J ^a   Klein, Barbara E K ^a   Klein, Ronald ^a   Nondahl, David M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE   (United States)

Author keywords

aging.; epidemiology; Olfaction; smell disorders

Indexed keywords

ANTILIPEMIC AGENT; STEROID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; EXERCISE; FEMALE; HEARING LOSS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; NOSE SEPTUM; PRIORITY JOURNAL; RISK FACTOR; SMELLING DISORDER;

ADRENAL CORTEX HORMONES; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOLISM; CROSS-SECTIONAL STUDIES; EXERCISE; FEMALE; HEALTH SURVEYS; HUMANS; HYPOLIPIDEMIC AGENTS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NASAL POLYPS; NASAL SEPTUM; OLFACTION DISORDERS; RISK FACTORS; SEX FACTORS; WISCONSIN;

EID: 79953092553     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21416     Document Type: Article

References (28)

1. Murphy C, Schubert CR, Cruickshanks KJ, Klein BEK, Klein R, Nondahl DM., Prevalence of olfactory impairment in older adults. JAMA 2002; 288: 2307-2312. (Pubitemid 35291761)
2. Bramerson A, Johansson L, Ek L, Nordin S, Bende M., Prevalence of olfactory dysfunction: the Skovde Population-Based Study. Laryngoscope 2004; 114: 733-737. (Pubitemid 38548788)
3. Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER., Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg 2001; 127: 497-503. (Pubitemid 32434044)
4. Hummel T, Nordin S., Olfactory disorders and their consequences for quality of life. Acta Oto-Laryngologica 2005; 125: 116-121. (Pubitemid 40293199)
5. Cruickshanks KJ, Wiley TL, Tweed TS, et al. Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. Am J Epidemiol 1998; 148: 879-886. (Pubitemid 28484107)
6. Cruickshanks KJ, Tweed TS, Wiley TL, et al. The 5-year incidence and progression of hearing loss. The Epidemiology of Hearing Loss Study. Arch Otolaryngol Head Neck Surg 2003; 129: 1041-1046. (Pubitemid 37248299)
7. Klein R, Klein BEK, Linton KLP, De Mets DL., The Beaver Dam Eye Study: visual acuity. Ophthalmology 1991; 98: 1310-1315.
8. Cruickshanks KJ, Nondahl DM, Tweed TS, et al. Education, occupation, noise exposure history and the 10-yr cumulative incidence of hearing impairment in older adults. Hear Res 2010; 264: 3-9.
9. Schubert CR, Cruickshanks KJ, Murphy C, et al. Olfactory impairment in adults. Ann NY Acad Sci 2009; 1170: 531-536.
10. Raynor LA, Pankow JS, Cruickshanks KJ, et al. Familial aggregation of olfactory impairment and odor identification in older adults. Laryngoscope 2010; 120: 1614-1618.
11. Krantz EM, Schubert CR, Dalton DS, et al. Test-retest reliability of the San Diego Odor Identification Test and comparison with the Brief Smell Identification Test. Chem Senses 2009; 34: 435-440.
12. Folstein MF, Folstein SE, McHugh PR., "Mini-Mental State," a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
13. Schubert CR, Carmichael LL, Murphy C, Klein BEI, Klein R, Cruickshanks KJ., Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. JAGS 2008; 56: 1517-1521.
14. Murphy C, Doty RL, Duncan HJ., Clinical disorders of olfaction. In:, Doty RL, ed. Handbook of Olfaction and Gustation. 2nd ed. New York: Marcel Dekker, Inc; 2003: 461-478.
15. Doty RL, Philip S, Reddy K, Kerr KL., Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: a review. J Hypertension 2003; 21: 1805-1813. (Pubitemid 37290095)
16. Doty RL, Bromley SM., Effects of drugs on olfaction and taste. Otolaryngol Clin N Am 2004; 37: 1229-1254. (Pubitemid 39572504)
17. Carlsson CM, Nondahl DM, Klein BEK, et al. Increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis. Alz Dis Assoc Disord 2009; 23: 11-17.
18. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998; 279: 1615-1622. (Pubitemid 28248586)
19. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307.
20. Franco OH, deLaet C, Peeters A, Jonker J, Mackenbach J, Nusselder W., Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med 2005; 165: 2355-2360. (Pubitemid 41640847)
21. Takemoto A, Liao JK., Pleiotropic effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase inhibitors. Arterioscler Thromb Vasc Biol 2001; 21: 1712-1719. (Pubitemid 34219772)
22. Mesholam RI, Moberg PJ, Mahr RN, Doty RL., Olfaction in neurodegenerative disease. A meta-analysis of olfactory functioning in Alzheimer's and Parkinson's Diseases. Arch Neurol 1998; 55: 84-90. (Pubitemid 28139109)
23. Wolfensberger M, Hummel T., Anti-inflammatory and surgical therapy of olfactory disorders related to sino-nasal disease. Chem Senses 2002; 27: 617-622.
24. Steven MH., Steroid-dependent anosmia. Laryngoscope 2001; 111: 200-203.
25. Heilmann S, Huettenbrink KB, Hummel T., Local and systemic administration of corticosteroids in the treatment of olfactory loss. Am J Rhinol 2004; 18: 29-33. (Pubitemid 38351411)
26. Rupp CI, Kurz M, Kemmler G, et al. Reduced olfactory sensitivity, discrimination and identification in patients with alcohol dependence. Alcohol Clin Exp Res 2003; 27: 432-439. (Pubitemid 36343287)
27. Ditraglia GM, Press DS, Butters N, et al. Assessment of olfactory deficits in detoxified alcoholics. Alcohol 1991; 8: 109-115.
28. Ship JA, Pearson JD, Cruise LJ, Brant LJ, Metter EJ., Longitudinal changes in smell identification. J Gerontol 1996; 51A (2): M86-M91.